v3.22.2.2
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Revenue        
Total revenue $ 317,001 $ 227,117 $ 849,955 $ 578,815
Operating expenses        
Cost of services, excluding depreciation and amortization 240,768 147,473 691,566 424,303
General and administrative expenses 21,388 21,813 53,224 45,476
Depreciation and amortization 4,754 4,671 13,480 13,105
Total expenses 266,910 173,957 758,270 482,884
Income from operations 50,091 53,160 91,685 95,931
Other (expense) income        
Income (loss) from equity method investments 1,452 132 4,397 (3,680)
Gain on sale of equity method investment 0 2,193 0 2,193
Interest expense (2,422) (967) (5,348) (4,343)
Interest income 223 420 690 1,331
Unrealized (loss) gain on investments (6,763) (60,943) (17,591) 22,826
Other (expense) income (1,318) 500 2,328 (14,080)
Total other (expense) income, net (8,828) (58,665) (15,524) 4,247
Income (loss) before provision for income taxes 41,263 (5,505) 76,161 100,178
Provision for (benefit from) income taxes 13,867 (120) 26,101 31,575
Net income (loss) 27,396 (5,385) 50,060 68,603
Net income (loss) attributable to non-controlling interest 1,410 (39,664) (1,589) 8,515
Net income attributable to Apollo Medical Holdings, Inc. $ 25,986 $ 34,279 $ 51,649 $ 60,088
Earnings per share – basic (in dollars per share) $ 0.58 $ 0.77 $ 1.15 $ 1.38
Earnings per share – diluted (in dollars per share) $ 0.56 $ 0.74 $ 1.12 $ 1.33
Capitation, net        
Revenue        
Total revenue $ 227,571 $ 149,059 $ 677,253 $ 438,350
Risk pool settlements and incentives        
Revenue        
Total revenue 64,849 59,923 101,717 94,146
Management fee income        
Revenue        
Total revenue 10,030 9,652 30,487 26,345
Fee-for-service, net        
Revenue        
Total revenue 12,859 7,260 35,694 14,968
Other income        
Revenue        
Total revenue $ 1,692 $ 1,223 $ 4,804 $ 5,006

Source